Ras signaling is tightly regulated during neural stem cell (NSC) differentiation, and defects in this pathway result in aberrant brain development. However, the mechanism regulating Ras signaling during NSC differentiation was unknown. Here, we show that stabilized HRas specifically induces neuronal differentiation of NSCs. Lentivirus-mediated HRas overexpression and knockdown resulted in stimulation and inhibition, respectively, of NSC differentiation into neuron in the ex vivo embryo. Retinoic acid, an active metabolite of vitamin A, promoted neuronal differentiation of NSCs by stabilizing HRas, and HRas knockdown blocked the retinoic acid effect. Vitamin-A-deficient mice displayed abnormal brain development with reduced HRas levels and a reduced thickness of the postmitotic region containing differentiated neurons. All of these abnormal phenotypes were rescued with the restoration of HRas protein levels achieved upon feeding with a retinoic-acidsupplemented diet. In summary, this study shows that retinoic acid stabilizes HRas protein during neurogenesis, and that this is required for NSC differentiation into neurons and murine brain development.
INTRODUCTION
Neural stem cells (NSCs) have a potential for self-renewal and can differentiate into neurons, astrocytes and oligodendrocytes during nervous system development (Miller and Gauthier, 2007) . The balance between NSC proliferation and differentiation is important for cell fate specification, which is determined by several extrinsic signaling molecules. Receptor tyrosine kinases (RTKs) have important roles in determining this balance, and their roles vary depending on the extrinsic stimuli (Annenkov, 2014; Patapoutian and Reichardt, 2001 ). For example, RTK activation by epidermal growth factor (EGF) and fibroblast growth factor (FGF) maintains NSC stemness, but RTK activation by neurotrophins induces NSC differentiation (Annenkov, 2014; Patapoutian and Reichardt, 2001 ). These context-specific RTK transduction cascades share the Ras signaling pathway as a common route. Therefore, tight regulation of Ras signaling is crucial to achieve spatiotemporal NSC differentiation and proper brain development (Kawabe and Brose, 2011) .
Aberrant regulation of the Ras signaling pathway has profound effects on neurogenic development and phenotypic brain features, including learning disabilities and mental retardation (Schubbert et al., 2007; Tidyman and Rauen, 2009) . Ras proteins appear to be important for central nervous system (CNS) development because HRas knockout or expression of HRas G12V in mice changes the long-term potentiation (LTP) and impairs cognitive development (Kushner et al., 2005; Manabe et al., 2000; Viosca et al., 2009) . Germline Ras mutations result in developmental brain disorders, and HRas mutations cause mental retardation in Costello syndromes (Adachi et al., 2012; Bentires-Alj et al., 2006; Kratz et al., 2006; Schubbert et al., 2007) . However, the role and regulation of HRas protein in neural differentiation and brain development were unknown.
Retinoic acid, a derivative of vitamin A, is one of the most important physiological signals for neuronal differentiation of NSCs (Maden, 2002; Siegenthaler et al., 2009 ). Disruption of retinoic acid signaling causes severe developmental abnormalities across multiple organ systems (Mark et al., 2009 ). However, the molecular mechanism underlying retinoic acid regulation of neuronal differentiation of NSCs and brain development has not been completely elucidated. Our previous work has shown that valproic acid, a drug used to treat epilepsy and bipolar disorder, increases pan-Ras levels during neuronal differentiation of NSCs (Jung et al., 2008) . In addition, we have investigated regulatory mechanisms of Ras protein stability in normal and cancer cells (Jeong et al., 2012; Kim et al., 2009; Moon et al., 2014) .
In this study, we investigated regulatory mechanisms determining HRas stability during NSC differentiation. We elucidated that HRas protein level is increased during neuronal differentiation of NSCs due to protein stabilization and not because of transcriptional induction. We performed HRas overexpression and knockdown analysis in vitro and in vivo to confirm that HRas is specifically involved in NSC differentiation into neurons during early mouse development, and that retinoic acid regulates HRas protein stability. This work indicates that vitamin A and its derivative retinoic acid might have therapeutic value for treating diseases involving neurological defects.
RESULTS

HRas is stabilized during NSC differentiation
To evaluate HRas involvement in NSC differentiation, HRas protein levels were measured before and after the removal of growth factors [EGF and basic FGF (bFGF) ], which induce differentiation (Jung et al., 2008) . HRas protein levels significantly increased during NSC differentiation, which was monitored by increases in the levels of known differentiation markers [Tuj1 for neurons (the neuronspecific class III β-tubulin), GFAP for astrocytes and MBP for oligodendrocytes] and decreases in the levels of NSC marker Sox2 and proliferation marker PCNA (Fig. 1A) . The level of active HRas protein was similarly increased during NSC differentiation ( Fig. 1A ; Fig. S1A ). Increases in HRas protein levels were due to increased protein abundance because there were no significant changes in the mRNA levels of HRas, KRas and NRas during neural differentiation, although increases in mRNA levels of Tuj1, GFAP and MBP, and a decrease in that of the NSC marker nestin (Nes) were observed (Fig. 1B) . We confirmed that increased HRas protein abundance was due to increased protein stability by treating with cycloheximide (CHX), which showed that the HRas protein halflife was 1 h in undifferentiated NSCs and >4 h in differentiated NSCs (Fig. 1C) . Treatment of NSCs with the proteosomal degradation pathway inhibitors N-acetyl-leucyl-leucyl-norleucinal (ALLN) and MG132 blocked Ras degradation (Fig. 1D) , which indicates that HRas protein is degraded through the proteasomal pathway. Associations between HRas protein stabilization and lineage-specific NSC differentiation also were investigated by immunocytochemical (ICC) analyses of HRas and known NSC differentiation markers after induction of differentiation by removal of growth factors (Fig. 1E,F ). Tuj1 and MBP co-stained with HRas, but GFAP did not (Fig. 1E ). After removal of growth factors, >42% of NSCs differentiated into neurons, whereas only 7% of NSCs differentiated into oligodendrocytes (Fig. S1B-D) . Quantitative analysis indicated that 91.8±1.96% of HRas-positive cells costained for Tuj1, compared to that for MBP co-staining (4.23± 1.28%) and GFAP co-staining (0.8±1.19%) (mean±s.d.; Fig. 1F) . These combined results demonstrate that HRas stabilization is strongly correlated with neuronal differentiation of NSCs. (A−C) NSCs isolated from E14.5 mouse brain were used with bFGF and EGF treatment (undifferentiated, UD) or after induction of differentiation (differentiated, D) by depleting bFGF and EGF for 4 days. (A) Whole-cell lysates (WCLs) were subjected to immunoblotting analyses for HRas, Tuj1, GFAP, MBP, Sox2, PCNA or β-actin. For GTP-HRas measurement, WCLs were incubated with GST-tagged Ras-binding domain (GST-RBD) and pulled down by GST agarose (PD:GST), and immunoblot analysis was performed using anti-HRas antibody. Ponceau S staining reveals the level of GST-RBD. (B) The mRNA levels of nestin, Tuj1, GFAP, MBP, and HRas, KRas and NRas were measured by qRT-PCR using GAPDH as an internal control. (C) Undifferentiated and differentiated NSCs were treated with cycloheximide (CHX; 25 µg/ml), and the relative HRas levels were determined at different time points by immunoblotting and densitometric scanning of the immunoblot. The 0 h band intensity was set to 1 (arbitrary units). (D) Undifferentiated NSCs were treated with either ALLN (25 µg/ml) or MG132 (10 µM) for 4 h. HRas levels were normalized with respect to β-actin as a loading control. Data are representative of three (B) and four (C,D) independent experiments. (E,F) NSCs were seeded on cove slips coated with poly-L-ornithine and fibronectin, and grown in N2 medium without bFGF and EGF for 4 days. (E) Cells were subjected to immunofluorescent staining to detect HRas (red), Tuj1, GFAP, MBP (green) and nuclei (DAPI, blue). Arrows indicate cells positive for both differentiation markers and HRas. (F) The numbers of cells positive for differentiation markers were normalized with respect to the numbers of HRas-positive cells. Approximately 300 cells were counted for each group from three independent experiments. Data are presented as mean±s.d. *P<0.05; ***P<0.005; n.s., not significant (Student's t-test).
HRas has a major role in neuronal differentiation of NSCs HRas overexpression in undifferentiated NSCs resulted in increased levels of the neuronal differentiation marker Tuj1, only weak expression of the astrocyte marker GFAP, and no induced expression of the oligodendrocyte marker MBP (Fig. 2A) . GFPHRas also co-stained with Tuj1 ( Fig. 2B; Fig. S2A ). The number of Tuj1-positive cells overexpressing GFP-HRas compared with the number of Tuj1-positive cells overexpressing GFP control were 16.5±2.72% and 3.2±0.49%, respectively (mean±s.d.; Fig. 2B,C) , which indicates an association between HRas and NSC differentiation. ICC analyses for Tuj1 and GFAP were used to distinguish the induction of neuronal differentiation versus glial differentiation in NSCs overexpressing HRas (Fig. 2B,C; Fig. S2A ), and the results indicated that HRas expression was associated with neuronal differentiation. Although GFP-HRas overexpression mildly increased the numbers of GFAP-positive cells, there were no GFAP-positive cells among those expressing GFP-HRas. GFPHRas overexpression barely induced MBP protein levels ( Fig. 2B,C ; Fig. S2A ), which was consistent with the immunoblotting data ( Fig. 2A) . In addition, the number of bromodeoxyuridine (BrdU)-positive cells were much lower among the cells overexpressing GFP-HRas compared with those expressing GFP (74.8±6.79% versus 42.9±8.08%) (Fig. S2B) . Overall, these results show that HRas has a role in neuronal differentiation of NSCs.
We used the lentiviral-based short hairpin RNA (shRNA) knockdown system to check the effects of HRas knockdown on NSC differentiation (Fig. 2D-F) . HRas knockdown inhibited Tuj1 induction, but did not inhibit the induction of GFAP and MBP during NSC differentiation (Fig. 2D) . The effect of HRas knockdown on neuronal differentiation of NSCs was evaluated by ICC analyses (Fig. 2E,F; Fig. S2C ). Cells expressing EGFP and shRNA targeting HRas (shHRas) expression reduced the percentage of cells positive for both Tuj1 and GFP from 34.9± 3.25% to 2.29±0.65% compared with that of cells expressing EGFP and shRNA targeting scrambled sequence (shSc) (Fig. 2F) . By contrast, HRas knockdown did not affect the percentage of GFAP-positive (26.5±1.86% versus 24.6±2.40%), MBP-positive (5.74±2.27% versus 5.32±1.61%) and BrdU-positive (27.9±2.74% versus 28.9±4.94%) cells compared with controls ( Fig. 2F; Fig. S2D ).
HRas is stabilized during neuronal differentiation of mouse embryo brain
HRas stabilization during in vivo neurogenesis was investigated by monitoring HRas protein levels in the developing cerebral cortex of mouse embryos. Immunoblotting analyses of mouse brain extracts using embryonic day (E)14.5, E16.5 and E18.5 embryos showed that HRas and Tuj1 levels were similarly increased (Fig. 3A) . The transcriptional induction of Tuj1 (but not HRas) was confirmed by real-time quantitative RT-PCR (qRT-PCR) analysis (Fig. 3B ). GFAP levels increased abruptly at E18.5 (Fig. 3A) , in agreement with a previous report (Barnabé-Heider et al., 2005) . Levels of the proliferation marker PCNA and the stemness marker Sox2 decreased with different kinetics during neurogenesis and developmental progression (Fig. 3A) . The HRas expression pattern in the developing embryo cerebral cortex at E14.5, E16.5 and E18.5 was verified by immunohistochemical (IHC) analyses 
-test).
At least three mice were examined per group. using the anti-HRas antibody, which has proven specificity for HRas protein (Fig. 3C) .
HRas levels increased concomitantly with Tuj1 levels in the intermediate zone (IZ) and cortical plate (CP) regions containing differentiated neurons, although HRas levels in the ventricular zone (VZ) and sub-ventricular zone (SVZ) also weakly increased (Fig. 3D ). The relative average Tuj1 levels and patterns were similar to those of HRas (Fig. 3E,F) . IHC analyses of E18.5 embryo extracts revealed HRas and Tuj1 co-staining in the CP region (Fig. 3G) . Expression of the mRNA transcripts for HRas was ubiquitous throughout the VZ and SVZ, IZ, and CP regions of mouse embryo brain (Fig. 3H ). These combined results indicate that HRas is stabilized during NSC differentiation, and HRas expression patterns positively correlate with Tuj1 expression in the developing embryo cerebral cortex.
Retinoic acid enhances HRas stability
Many studies have reported that retinoic acid has an important role in neuronal differentiation of NSCs during development of the nervous system (Maden, 2002; Siegenthaler et al., 2009) . Therefore, we investigated the effects of retinoic acid on Ras stability in NSCs. Retinoic acid treatment of NSCs increased HRas and Tuj1 levels together with the increase in the active HRas level (Fig. 4A) . The HRas mRNA levels were not changed by retinoic acid treatment, whereas retinoic acid induced Tuj1 transcription (Fig. 4B) . The level of HRas was increased within 5 min and it accumulated to high levels within an hour after retinoic acid treatment (Fig. 4C) . Retinoic-acidmediated HRas stabilization also was examined by live-cell imaging of NSCs transfected with GFP-HRas and control RFP ( Fig. 4D ; Movie 1). Rapid stabilization of HRas by retinoic acid was indicated by membranous accumulation of GFP-HRas (but not RFP) within an hour after retinoic acid treatment ( Fig. 4D; Movie 1) . Retinoic-acidmediated HRas stabilization also was confirmed by fluorescence activated cell sorting (FACS) analyses of NSCs transfected with GFP-HRas and control GFP, which detected GFP-HRas increases at 12 h after retinoic acid treatment (9.57±1.58%) compared with the GFP control (2.73±0.48%) (mean±s.d.; Fig. 4E; Fig. S3A ).
Immunoblotting ( Fig. 4F ) and ICC analyses ( Fig. 4G,H ; Fig. S3B ) indicated that retinoic-acid-mediated neuronal differentiation of NSCs was synergistically enhanced by HRas overexpression. These results showed that retinoic acid treatment of HRas-overexpressing cells further enhanced the percentage of Tuj1-positive cells (26.3±4.56%) compared to that of retinoic acid treatment of GFP-overexpressing cells (13.5±2.36%) or HRasoverexpressing cells (16.6±3.76%) (Fig. 4G,H; Fig. S3B ). Retinoic acid treatment of HRas-overexpressing cells further reduced the percentage of BrdU-positive cells (30.0±5.25%) compared to that of retinoic acid treatment of GFP-overexpressing cells (48.4±3.32%) or HRas-overexpressing cells (39.5±3.79%) (Fig. S3C) .
By contrast, HRas knockdown blocked retinoic-acid-mediated neuronal differentiation of NSCs as analyzed by immunoblotting (Fig. 4I) and ICC ( Fig. 4J,K; Fig. S3D ). Retinoic acid treatment of shSc-infected NSCs induced neuronal differentiation, with the percentage of dual Tuj1 + and GFP + cells being increased (0.64%±0.36% versus 13.7%±1.68% upon treatment) ( Fig. 4J,K;  Fig. S3D ). However, retinoic acid treatment of shHRas-infected NSCs reduced neuronal differentiation compared to that of shSc-infected cells, with percentages of dual Tuj1 + and GFP + cells of 2.09±0.85% and 13.7±1.68%, respectively ( Fig. 4J,K ; Fig. S3D ). HRas knockdown did not affect the proliferation of NSCs (Fig. S3E) . These combined results indicate that retinoic acid induces neuronal differentiation of NSCs by stabilizing HRas.
HRas stabilization has a role in neuronal differentiation of NSCs in ex vivo cultured mouse embryo brain
To investigate the role of HRas in neuronal differentiation in vivo, we injected concentrated lentivirus into the cerebral cortices of E13.5 embryos by intraventricular microinjection, and then incubated the embryos for 72 h using the roller-bottle incubating system (Fig. 5A) . GFP-positive NSCs expressing HRas shRNA were identified at the VZ and SVZ region (Fig. 5B,C) . Magnified views of cortex expressing shHRas showed that GFP-positive NSCs co-stained with PCNA but not with Tuj1 (Fig. 5B,C) . HRas knockdown increased the percentage of undifferentiated cells from 10.2±3.2% to 78.3± 4.4% in the VZ and SVZ region (mean±s.d.; Fig. 5D ). By contrast, GFP-HRas overexpression increased the number of Tuj1-positive cells in the CP region and reduced the number of PCNA-positive cells in the VZ and SVZ region, indicating that GFP-HRas overexpression increased NSC neuronal differentiation (Fig. 5E,F) . Co-expression of Tuj1, but not PCNA, in GFP-positive HRasoverexpressing cells supports a role for HRas in neuronal differentiation of NSCs (Fig. 5E,F) . A total of 75.2±7.1% of GFPHRas-overexpressing cells were Tuj1-positive in the CP region, compared to 48.9±4.1% of control GFP-expressing cells (Fig. 5G) . These results indicate that HRas stabilization induces neuronal differentiation of NSCs in vivo during mouse embryogenesis.
Vitamin A deficiency disrupts HRas stabilization with aberrant brain development, and these effects are rescued by retinoic acid
We used a vitamin A deficiency (VAD) mouse model system (Misner et al., 2001; White et al., 2000) to evaluate the in vivo role of HRas stabilization in retinoic-acid-mediated neurogenesis. Female mice were fed a VAD diet without retinoic acid supplementation for 4 months before mating with male mice. At E9.5, the mated female mice were separated into two groups; one VAD group continued to be fed a low-retinoic-acid diet (0.5 µg all-trans retinoic acid/g diet), whereas the other VAD group was fed a diet supplemented with high-RA (250 µg all-trans retinoic acid/g diet) [vitamin-A-sufficient (VAS) group]. Embryos were obtained from both groups at E14.5, E16.5 and E18.5 (Fig. 6A) . Vitamin A deficiency symptoms include cloudy eyes and matted hair (Misner et al., 2001 ). These symptoms were confirmed in the experimental dams. Additional effects of the low-retinoic acid VAD diet included reduced and delayed embryo development, reduced embryo size (Fig. S4A ) and reduced thickness of the IZ and CP regions (but no change in the VZ and SVZ regions) in the brain cortex as observed by hematoxylin and eosin (H&E) staining (Fig. S4B−D) . All of these defects and/or abnormalities were rescued in VAS embryos (Fig. S4B−D) . Embryo brains obtained from the VAD diet group exhibited developmental brain defects, with reductions of HRas and Tuj1 and increases of Sox2 and PCNA, compared with embryo brains from the VAS diet group (Fig. 6B) . The effects of VAD and VAS diets on HRas stabilization and NSC differentiation in embryo brains were evaluated by performing IHC analyses to determine specific expression patterns of HRas in relation to that of the markers ( Fig. 6C−G; Fig. S4E ). The VAD diet reduced HRas levels, which were rescued by retinoic acid supplementation; IHC analyses detected higher HRas levels in embryo brains from the high-retinoic-acid VAS diet group than in those of the low-retinoicacid VAD diet group, especially in the postmitotic region of all three embryonic stages examined (E14.5, E16.5 and E18.5) ( Fig. 6C−F;  Fig. S4E ). By contrast, there were no significant differences in HRas protein levels in the VZ and SVZ region in VAD and VAS diet groups ( Fig. 6C−E) . Furthermore, the low-retinoic-acid VAD diet group exhibited reduced HRas levels and fewer cells co-stained with Tuj1 and HRas than those in the high-retinoic-acid VAS diet group, especially at the tip of the CP region (Fig. 6G) . These combined results indicate that retinoic-acid-mediated HRas stabilization has a role in neuronal differentiation of NSCs and early brain development of mice embryos, which require vitamin A.
DISCUSSION
Many studies have documented the role of RTK-Ras signaling in neuronal differentiation of NSCs and CNS function. Gene mutations in the RTK-Ras signaling pathway result in developmental disorders such as mental retardation and epilepsy (Adachi et al., 2012; Bentires-Alj et al., 2006) . Most physiological studies of Ras in NSCs focus on the Ras GTPase-activating protein (GAP; e.g. NF1) and its scaffolding protein Sur8 (also known SHOC2) (Moon et al., 2011; Phoenix and Temple, 2010) . In addition, most neurological studies of Ras focus on the CNS of adult mice (Kushner et al., 2005; Manabe et al., 2000; Viosca et al., 2009) ; however, the regulatory mechanism and role of Ras during CNS development is still unclear.
In this study, we identified that HRas protein is stabilized during neuronal differentiation of NSCs, and this stabilization is directly related to neurogenesis and brain development in the mouse embryo. HRas was specifically stabilized during neuronal differentiation. More than 90% of HRas-positive cells co-stained for Tuj1 in differentiating NSCs. HRas knockdown specifically inhibited neuronal differentiation without changing astrocyte or oligodendrocyte differentiation. HRas overexpression strongly induced Tuj1 and only weakly induced the astrocyte marker GFAP. However, the induced GFAP did not co-stain with HRas, which could mean that an alternative extrinsic factor is secreted from neurons (Barnabé-Heider et al., 2005; Miller and Gauthier, 2007) . We found that the increment or decrement of neuronal differentiation by HRas overexpression or knockdown did not induce proliferation or reduce survival of NSCs, respectively. RTKRas signaling events elicit different biological responses through sustained versus transient activation of downstream effectors (Andreu-Perez et al., 2011) . Hence, we measured the activity of HRas, and observed an activation of HRas with its stabilization during differentiation of NSCs. In addition, we confirmed that the sustained activation of HRas was increased proportionally to the stabilization of HRas in a time-dependent manner during NSC differentiation. Taken together, our data suggest that H-Ras stabilization plays a role in the determination of the cell fate, and especially in neuronal differentiation, but not in astrocyte or oligodendrocyte differentiation, of NSCs. Similarly, activated HRas has been reported to promote differentiation and growth arrest, in contrast to activated KRas, which promotes proliferation in endodermal progenitor cells (Quinlan et al., 2008) . In addition, activated KRas, but not HRas or NRas, has been reported to induce proliferation of NSCs (Bender et al., 2015) . Taken together, these data imply that each Ras isotype plays divergent roles in NSC differentiation and proliferation, although they share the same upstream RTK-Ras cascade. Thus, fine and differential regulations of this signal transduction pathway is critical for regulation of differentiation.
The role of HRas in neuronal differentiation of NSCs was confirmed by ex vivo experiments showing that HRas knockdown and overexpression resulted in suppression and activation, respectively, of NSC differentiation into neurons, especially in the IZ and CP regions of E13.5 embryos. HRas protein levels increased primarily in the IZ and CP regions of mouse brain during embryonic days E14.5-E18.5, when neurons are generated and matured (Miller and Gauthier, 2007) . This suggests that HRas might predominantly have a role in NSC differentiation during early brain development and neurogenesis. A previous study has reported that HRas is recruited to the axonal growth cone during polarity formation in the hippocampal neuron (Fivaz et al., 2008) , which is consistent with our results showing a role for HRas in neuronal differentiation of NSCs and early neurogenesis.
Retinoic acid treatment of NSCs stabilizes HRas with the increase in its activity resulting in NSC differentiation into neurons. ICC analyses detected a retinoic-acid-mediated increase in the number of cells co-expressing both HRas and Tuj1, and a synergistic effect of HRas overexpression and retinoic acid treatment on neuronal differentiation of NSCs. HRas knockdown suppressed retinoicacid-mediated Tuj1 induction, which provided further evidence supporting the role of HRas in retinoic-acid-induced neuronal differentiation. Embryos depend on maternal nutrition for their dietary needs. Depletion of vitamin A in dams resulted in vitamin-A-deficient embryos, which exhibited developmental delays and reduced thickness of the postmitotic cortical region compared with embryos of dams fed a normal or VAS diet. The vitamin-A-deficient embryos exhibited lower Tuj1 and HRas protein levels in the IZ and CP regions, but no change in Tuj1 and HRas levels in the VZ and SVZ regions. These results indicate that defective neuronal differentiation in embryos of dams fed a low-retinoic-acid VAD diet might be caused by vitamin A deficiency. Reduced Tuj1 and HRas protein levels in VAD embryos were completely rescued by retinoic acid supplementation. These results correlate with those from a previous study suggesting the importance of retinoic acid and vitamin A for normal embryonic brain development and neurogenesis (White et al., 2000) .
In summary, our studies have identified that HRas is stabilized during neuronal differentiation of NSCs in early brain development. HRas stabilization is essential for retinoic-acid-induced neuronal differentiation during normal brain development. Vitamin A and its derivative retinoic acid can potentially be used for therapeutic treatment of diseases involving neural defects such as mental retardation and epilepsy that are due to aberrant HRas and its modulators (Adachi et al., 2012; Bentires-Alj et al., 2006) .
MATERIALS AND METHODS
Primary NSC cultures
Primary NSCs were isolated from the telencephalon of C57/BL6 mouse embryos at E14 (Sher et al., 2008) as described previously (Moon et al., 2011) . Cells were grown in N2 medium [Dulbecco's Modified Eagle's Medium (DMEM):F12 (1:1) (Gibco, Carlsbad, CA) containing 100 μM putrescine, 30 nM selenite, 20 nM progesterone, 1.55 mg/ml D-(+)-glucose, 25 μg/ml insulin, 0.1 μg/ml apo-transferrin (Sigma-Aldrich), 0.5 mM glutamax, 100 IU/ml penicillin, and 100 μg/ml streptomycin] in the presence of 20 ng/ml bFGF (Peprotech, Princeton, NJ) and 20 ng/ml EGF (Peprotech) in a humidified atmosphere of 95% air and 5% CO 2 at 37°C (Bottenstein and Sato, 1979) . Cells were dissociated with TrypLE (Gibco) and cultured on plates coated with poly-L-ornithine ( pLO, 15 μg/ml; SigmaAldrich) and fibronectin (1 μg/ml; Gibco). To induce normal differentiation, growth factors were withdrawn from N2 medium. For retinoic-acid-induced differentiation, 1 μM retinoic acid (Sigma-Aldrich) was added to medium along with growth factors for 4 days. Media were changed every second day. Plasmid transfections were performed with Lipofectamine (Invitrogen) according to the manufacturer's instructions. The following reagents (all from Sigma-Aldrich) were administered at the indicated concentrations: cycloheximide (CHX; 25 µg/ml), N-acetyl-leucyl-leucyl-norleucinal (ALLN; 25 µg/ml), MG132 (10 µM) and retinoic acid (1 µM).
Plasmids
The following plasmids were used in these experiments and have been described previously (Jeon et al., 2007; Kim et al., 2009; Park et al., 2006) : pcDNA3.1, pcDNA3.1-HRas, pEGFP-C3, pEGFP-C3-HRas and pcDNA3.1-RFP. The plasmid for production of the glutathione Stransferase (GST)-tagged Ras-binding domain (GST-RBD) was provided by Richard A. Firtel (Section of Cell & Developmental Biology, University of California, San Diego, CA) (Sasaki et al., 2007) . For lentivirus production, the shRNA expression vector pLKO.1-puro (Addgene, Cambridge, MA) was used as backbone vector. The pLKO.1-shHRas constructs were purchased from Sigma-Aldrich. For EGFP expression in infected cells, the EGFP-IRES sequence was introduced between the PGK promoter and the puromycin resistance gene. For lentiviral overexpression, the pLVX-IRES-Hyg vector (Clonetech, Palo Alto, CA) was used. For PCR amplification of the HRas open reading frame (ORF) sequence, the following primers were used: forward, 5′-GAGCGGCCGCGGATCCAT-GACGGAATATAAGCT-3′; reverse 5′-GAGAGGGGCGGGATCCTCA-GGAGAGCACACACT-3′. The PCR product was introduced using the BamHI restriction enzyme site. The lentiviral packaging plasmids psPAX2 and pMD2.G were used for lentivirus production.
RNA preparation and RT-PCR
Total RNA was extracted using the TRIzol reagent (Invitrogen). Reverse transcription was performed with M-MLV reverse transcriptase (Invitrogen) using 2 μg of total RNA. PCR reactions were performed with Ex-Taq DNA polymerase (SG Bio, Kyunggi Do, Korea) at 95°C for 5 min, followed by 25 −35 cycles at 95°C for 30 s, 55−62°C for 30 s, and 72°C for 30 s in a System 2700 cycler (Applied Biosystems, Foster City, CA). The primer sets used for RT-PCR detection of mRNAs for HRas, Tuj1 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) are listed in Table S1 .
Real-time quantitative PCR analysis
Synthesized cDNA was diluted to a concentration of 100 ng/µl. qRT-PCR analyses were performed in a Rotor-gene Q real-time PCR cycler (Qiagen, Valencia, CA) using SYBR green reagent (Qiagen) with conditions of 95°C for 10 min followed by 40 cycles at 95°C for 5 s and 60°C for 15 s. Relative quantitation of mRNA levels of Tuj1, GFAP, MBP, Nestin, and HRas, KRas and NRas was estimated using the comparative Ct method (ΔΔCt) (Moon et al., 2011) . All mRNA values were normalized with respect to GAPDH. PCR primer sequences are listed in Table S2 .
Immunoblot analysis
Immunoblotting was performed as described previously (Jeong et al., 2012) . Briefly, cells were washed in ice-cold phosphate buffered saline (PBS; Gibco) and lysed with radioimmunoprecipitation assay (RIPA) buffer (Millipore, Billerica, MA) . Equal amounts of protein (10−25 μg/lane) were loaded onto a 12% SDS-PAGE gel and subsequently transferred to nitrocellulose membranes. Membranes were blocked with 5% skim milk in PBS for 1 h at room temperature, and then blotted overnight with the appropriate antibody at 4°C. The following antibodies and dilutions were used: HRas (1:1000; sc-520, Santa Cruz Biotechnology), Tuj1 (1:3000; MAB 1195, R&D Systems, Minneapolis, MN), GFAP (1:3000; #3670s, Cell Signaling), MBP (1:1000; sc-66064, Santa Cruz Biotechnology), PCNA (1:1000; sc-56, Santa Cruz Biotechnology), β-actin (1:1000; sc-47778, Santa Cruz Biotechnology), K-Ras (1:1000; sc-30, Santa Cruz Biotechnology), N-Ras (1:1000; sc-31, Santa Cruz Biotechnology), ERK proteins (1:1000; sc-94, Santa Cruz Biotechnology), and Sox2 (1:1000; sc-365823, Santa Cruz Biotechnology). Horseradish-peroxidase-conjugated anti-mouse-IgG (Cell Signaling) and anti-rabbit-IgG (Bio-Rad, Hercules, CA) secondary antibodies were used at 1:3000 dilutions for 1 h at room temperature. Protein bands were visualized with enhanced chemiluminescence (Amersham Bioscience, Buckinghamshire, UK) using a luminescent image analyzer (LAS-3000; Fujifilm, Tokyo, Japan).
Ras GTP loading assay
The Ras GTP loading assay was performed as described previously (Kaduwal et al., 2015; Sasaki et al., 2007) . In brief, cell lysates were incubated with bacterially produced GST-RBD protein bound to glutathione-coupled agarose beads. The proteins bound to the beads were washed three times with lysis buffer (10% glycerol, 50 mM Tris-HCl pH 7.4, 100 mM NaCl, 1% NP-40, 2 mM MgCl 2 ), eluted in 3× Laemmli sample buffer, and analyzed for GTP-Ras by immunoblotting with an antiHRas antibody.
Immunocytochemistry and BrdU incorporation assay
For the BrdU incorporation assay, cells were grown for 6 h in N2 media containing 20 µM BrdU. Cells were fixed with 4% paraformaldehyde in PBS for 10 min and the BrdU-treated cells were incubated in 2 M HCl for 30 min. The cells were permeabilized with 0.1% Triton X-100 in PBS for 15 min, and incubated in blocking solution [5% bovine serum albumin (BSA) and 1% normal goat serum (NGS) in PBS] for 30 min. Then, cells were incubated with selected antibodies in a solution containing 1% BSA and 1% NGS in PBS at 4°C overnight. The following antibodies and dilutions were used: pan-Ras (1:300; 05-516, Millipore), Tuj1 (1:300; MAB 1195, R&D Systems), GFAP (1:300; #3670s, Cell Signaling), MBP (1:100; sc-66064, Santa Cruz Biotechnology), BrdU (1:300; M0744, Dako), GFP (1:500; sc-9996, Santa Cruz Biotechnology) and PCNA (1:100; sc-56, Santa Cruz Biotechnology). Cells were washed three times in PBS and incubated with Alexa-Fluor-488-or Alexa-Fluor-555-conjugated IgG secondary antibody (Molecular Probes) for 1 h at room temperature. Nuclei were counterstained by incubating in 1 μg/ml DAPI (4′,6-diamidino-2-phenylindole; Boehringer Mannheim, Indianapolis, IN) for 10 min. Coverslips were mounted using GelMount (Biomeda Corporation, Foster City, CA).
Virus production and viral packaging
Lentiviral plasmid was co-transfected with the packaging plasmids psPAX2 and pMD2.G into HEK 293T cells using a ratio of 2:1.2:0.8, respectively. Lentivirus-containing medium was collected twice every 24 h and filtered through 0.45 µm pore filters (Millipore). During ultraconcentration of virus in two steps, FBS was removed; first, samples were filtered through Centricon filters (Millipore) with a 100-kDa cut-off, and then subjected to ultracentrifugation of 100,000 g for 2 h at 4°C. Concentrated lentivirus was reconstituted in PBS, prepared as 10 µl aliquots, and stored at −80°C. Virus titer was calculated by GFP expression after HEK293 cell infection. NSCs were treated with lentiviral titers of ∼10 6 −10 7 transduction units per ml.
Live-cell imaging
Coverslips were placed into six-well plates, and NSCs were plated on the coverslips. The cells were transfected with pEGFP-C3-HRas and pcDNA3.1-RFP. Fluorescence was observed before cell imaging using a Nikon TE 2000-U inverted microscope (Nikon, Tokyo, Japan). Then, coverslips were moved to the Chamlide TC chamber (Live Cell Instrument, Seoul, Korea) and mounted on a Nikon Ti-eclipse microscope (Nikon, Tokyo, Japan) equipped with a Chamlide TC incubator system (Live Cell Instrument), which maintains 37°C and 5% CO 2 humidity for live-cell imaging.
Flow cytometry
Cells were trypsinized with TrypLE (Gibco) before flow cytometry. Then, 10,000 cells positioned on the right side of the P1 gate were collected using the BD Accuri Flow Cytometer (BD Biosciences, San Jose, CA). Each sample was analyzed using BD Accuri C6 software (BD Biosciences), and results for GFP intensity were plotted in histograms.
Animals and dietary treatments
C57BL/6N mice were housed under standard conditions in a specificpathogen-free facility. All animal protocols were approved by the Institutional Animal Care and Use Committee, Yonsei University (IACUC-A-201407-263-01 and IACUC-A-201411-327-01). For depletion of vitamin A, C57BL/6N female mice were fed the modified AIN 93G diet that lacks vitamin A (0 µg all-trans retinoic acid/g diet) (Dyets, Bethlehem, PA) for at least for 4 months, and then mated with male mice. A plug check was performed. To avoid embryonic resorption, dams from E9.5 were maintained either on low-retinoic acid VAD diet (0.5 µg all-trans retinoic acid /g diet) (Dyets) or on high-retinoic acid VAS diet (250 µg all-trans retinoic acid/g diet) (Dyets). Dams were killed by carbon dioxide inhalation and embryos were collected at E14.5, E16.5 and E18.5.
Whole embryo organ culture
Ex vivo culture of whole embryo was performed as previously described (Moon et al., 2011) . GFP, GFP-HRas, shSc or shHRas lentivirus was mixed with 0.1% Fast Green dye (Sigma-Aldrich), and 1 µl of virus was injected by intraventricular microinjection using a fine glass needle. Virus-infected whole embryos were placed in culture bottles (NuAire Inc., Plymouth, MN) containing 10 ml DMEM with 20% FBS, followed by wheel rotation (Wheaton Science Products, Millville, NJ) at 20 rpm. The embryos were incubated at 37°C in 50% O 2 , 45% N 2 and 5% CO 2 . Media and gasses were replaced every day during the 3 days of culture.
Immunohistochemistry
Paraformaldehyde-fixed paraffin sections were deparaffinized and rehydrated. For antigen retrieval, the slides were autoclaved in retrieval buffer (10 mM sodium citrate buffer, pH 6.0; Sigma-Aldrich). Sections were incubated in blocking solution for 30 min at room temperature. The sections were incubated overnight with the following primary antibodies at 4°C: Pan-Ras (1:300; 05-516, Millipore), Tuj1 (1:300; MAB 1195, R&D Systems), HRas (1:100; sc-520, Santa Cruz Biotechnology), GFP (1:500; sc-9996, Santa Cruz Biotechnology), and PCNA (1:100; sc-56, Santa Cruz Biotechnology). For immunofluorescence staining, the sections were incubated with Alexa-Fluor-488-or Alexa-Fluor-555-conjugated IgG secondary antibody (Molecular Probes) for 1 h at room temperature. Nuclei were counterstained by incubation in 1 μg/ml DAPI for 10 min.
In situ hybridization
Paraformaldehyde-fixed paraffin sections were deparaffinized and rehydrated. Sections were incubated in fixation solution (4% PFA in PBS) for 10 min at room temperature. Sections were treated with proteinase K solution (10 µg/ml in 50 mM Tris-HCl and 5 mM EDTA, pH 8.0) for 10 min at 37°C to remove protein. Sections were incubated in 5× SSC buffer for 15 min, and incubated with pre-hybridization buffer (5× SSC, 50% formamide, pH to 7.5 with HCl, 0.1% Tween 20, 50 µg/ml salmon sperm DNA, 50 µg/ml yeast tRNA) for 2 h at 58°C. Digoxigenin-riboprobes (100-500 ng/ml) were hybridized with the sections by incubating in prehybridization buffer for 24 h at 58°C. Then, sections were sequentially washed with 2× SSC and 0.1× SSC buffer for 1 h at 65°C. Sections were washed with PBS and incubated in PBS containing 1% BSA and 0.2% Triton X-100 for 30 min. Sections were incubated with alkalinephosphatase-conjugated anti-digoxigenin antibody (Roche) at 1:500 dilution in PBS containing 1% BSA and 1% NGS for 1 h, followed by washing with PBS three times for 5 min each. Finally, sections were incubated in solution containing Nitro blue Tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) (Sigma-Aldrich) for color development.
Statistical analysis
Data are presented as mean±s.d. Statistical analyses were performed using unpaired two-tailed Student's t-test. Asterisks denote statistically significant differences (*P<0.05; **P<0.01; ***P<0.005, n.s., not significant).
